Table 3 The relationship between the expression of microRNA-92a and clinical characteristics of osteosarcoma patients [n (%)]
Clinicopathological feature | Case | miR-92a expression | P | |
|---|---|---|---|---|
Positive (n = 46) | Negative (n = 12) | |||
Age (years) | Â | Â | Â | 0.756 |
 ≤ 20 | 31 | 24 (52.2) | 7 (58.3) |  |
 > 20 | 27 | 22 (47.8) | 5 (41.7) |  |
Gender | Â | Â | Â | 0.342 |
 Male | 36 | 27 (58.7) | 9 (75.0) |  |
 Female | 22 | 19 (41.3) | 3 (25.0) |  |
Tumor location | Â | Â | Â | 0.603 |
 Femur | 22 | 16 (34.8) | 6 (50.0) |  |
 Tibiofibular | 20 | 17 (37.0) | 3 (25.0) |  |
 Other | 16 | 13 (28.2) | 3 (25.0) |  |
Histological type | Â | Â | Â | 0.107 |
 Osteoblast type | 18 | 11 (23.9) | 7 (58.3) |  |
 Chondroblast type | 15 | 12 (26.1) | 3 (25.0) |  |
 Fibroblast type | 14 | 13 (28.3) | 1 (8.35) |  |
 Mixed type | 11 | 10 (21.7) | 1 (8.35) |  |
Ennecking stage | Â | Â | Â | 0.020 |
 I + IIA | 21 | 13 (28.3) | 8 (66.7) |  |
 IIB + III | 37 | 33 (71.7) | 4 (33.3) |  |
Distant metastasis | Â | Â | Â | 0.009 |
 Yes | 30 | 28 (60.9) | 2 (16.7) |  |
 No | 28 | 18 (39.1) | 10 (83.3) |  |